Ulcerative Colitis Market 2027 By Drug Type, Disease Type, Distribution Channel | The Insight Partners

Ulcerative Colitis Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Drug Type (Aminosalicylates, Corticosteroids, Immunomodulators, Antibiotics, Other Drug Types); Disease Type (Mild Ulcerative Colitis, Moderate Ulcerative Colitis, Severe Ulcerative Colitis); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales)

Report Code: TIPRE00007751 | No. of Pages: 151 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Ulcerative colitis is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers in the digestive tract. Ulcerative colitis affects the innermost lining of the large intestine and rectum. Symptoms of ulcerative colitis usually develop over time, rather than suddenly. It occurs in people aged 15years to 30 years.

MARKET DYNAMICS

The ulcerative colitis market is anticipated to grow by the increasing prevalence of a disease that affects millions of people globally. However, patent expiry of drugs and strict government regulations towards the approval of biosimilars restrain the market growth. Also, huge R&D and investment did by key players towards the development of novel therapies for UC treatment and rise in government and non-government organizations towards research in biologics further drive the market growth.

MARKET SCOPE

The "Ulcerative Colitis Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in ulcerative colitis market with detailed market segmentation by drug type, disease type, distribution channel and geography. The ulcerative colitis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in ulcerative colitis market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The ulcerative colitis market is segmented on the basis of drug type, disease type, distribution channel. Based on drug type the market is segmented as amino salicylates, corticosteroids, immunomodulators, antibiotics and other drug types. On the basis of distribution channel the market is categorized as mild ulcerative colitis, moderate ulcerative colitis and severe ulcerative colitis. On the basis of distribution channel the market is categorized as hospital pharmacies, retail pharmacies and online sales.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in ulcerative colitis market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The ulcerative colitis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting ulcerative colitis market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the ulcerative colitis market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in ulcerative colitis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in ulcerative colitis market are anticipated to have lucrative growth opportunities in the future with the rising demand for in ulcerative colitis market in the global market. Below mentioned is the list of few companies engaged in the in ulcerative colitis market.

The report also includes the profiles of key in ulcerative colitis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbott
  •  AbbVie Inc.
  •  COSMO PHARMACEUTICALS
  •  EA Pharma Co., Ltd.
  •  F. Hoffmann-La Roche Ltd
  •  Johnson and Johnson Services, Inc.
  •  Pfizer Inc.
  •  Salix Pharmaceuticals
  •  Takeda Pharmaceutical Company Limited.
  •  Teva Pharmaceutical Industries Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Ulcerative Colitis Therapeutics Market - By Drug Type
1.3.2 Ulcerative Colitis Therapeutics Market - By Disease Type
1.3.3 Ulcerative Colitis Therapeutics Market - By Distribution Channel
1.3.4 Ulcerative Colitis Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ULCERATIVE COLITIS THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ULCERATIVE COLITIS THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ULCERATIVE COLITIS THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ULCERATIVE COLITIS THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ULCERATIVE COLITIS THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ULCERATIVE COLITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. AMINOSALICYLATES
7.3.1. Overview
7.3.2. Aminosalicylates Market Forecast and Analysis
7.4. CORTICOSTEROIDS
7.4.1. Overview
7.4.2. Corticosteroids Market Forecast and Analysis
7.5. IMMUNOMODULATORS
7.5.1. Overview
7.5.2. Immunomodulators Market Forecast and Analysis
7.6. ANTIBIOTICS
7.6.1. Overview
7.6.2. Antibiotics Market Forecast and Analysis
7.7. OTHER DRUG TYPES
7.7.1. Overview
7.7.2. Other Drug Types Market Forecast and Analysis
8. ULCERATIVE COLITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE TYPE
8.1. OVERVIEW
8.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
8.3. MILD ULCERATIVE COLITIS
8.3.1. Overview
8.3.2. Mild Ulcerative Colitis Market Forecast and Analysis
8.4. MODERATE ULCERATIVE COLITIS
8.4.1. Overview
8.4.2. Moderate Ulcerative Colitis Market Forecast and Analysis
8.5. SEVERE ULCERATIVE COLITIS
8.5.1. Overview
8.5.2. Severe Ulcerative Colitis Market Forecast and Analysis
9. ULCERATIVE COLITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE SALES
9.5.1. Overview
9.5.2. Online Sales Market Forecast and Analysis
10. ULCERATIVE COLITIS THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Ulcerative Colitis Therapeutics Market Overview
10.1.2 North America Ulcerative Colitis Therapeutics Market Forecasts and Analysis
10.1.3 North America Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Drug Type
10.1.4 North America Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Disease Type
10.1.5 North America Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Ulcerative Colitis Therapeutics Market
10.1.6.1.1 United States Ulcerative Colitis Therapeutics Market by Drug Type
10.1.6.1.2 United States Ulcerative Colitis Therapeutics Market by Disease Type
10.1.6.1.3 United States Ulcerative Colitis Therapeutics Market by Distribution Channel
10.1.6.2 Canada Ulcerative Colitis Therapeutics Market
10.1.6.2.1 Canada Ulcerative Colitis Therapeutics Market by Drug Type
10.1.6.2.2 Canada Ulcerative Colitis Therapeutics Market by Disease Type
10.1.6.2.3 Canada Ulcerative Colitis Therapeutics Market by Distribution Channel
10.1.6.3 Mexico Ulcerative Colitis Therapeutics Market
10.1.6.3.1 Mexico Ulcerative Colitis Therapeutics Market by Drug Type
10.1.6.3.2 Mexico Ulcerative Colitis Therapeutics Market by Disease Type
10.1.6.3.3 Mexico Ulcerative Colitis Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Ulcerative Colitis Therapeutics Market Overview
10.2.2 Europe Ulcerative Colitis Therapeutics Market Forecasts and Analysis
10.2.3 Europe Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Disease Type
10.2.5 Europe Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Ulcerative Colitis Therapeutics Market
10.2.6.1.1 Germany Ulcerative Colitis Therapeutics Market by Drug Type
10.2.6.1.2 Germany Ulcerative Colitis Therapeutics Market by Disease Type
10.2.6.1.3 Germany Ulcerative Colitis Therapeutics Market by Distribution Channel
10.2.6.2 France Ulcerative Colitis Therapeutics Market
10.2.6.2.1 France Ulcerative Colitis Therapeutics Market by Drug Type
10.2.6.2.2 France Ulcerative Colitis Therapeutics Market by Disease Type
10.2.6.2.3 France Ulcerative Colitis Therapeutics Market by Distribution Channel
10.2.6.3 Italy Ulcerative Colitis Therapeutics Market
10.2.6.3.1 Italy Ulcerative Colitis Therapeutics Market by Drug Type
10.2.6.3.2 Italy Ulcerative Colitis Therapeutics Market by Disease Type
10.2.6.3.3 Italy Ulcerative Colitis Therapeutics Market by Distribution Channel
10.2.6.4 Spain Ulcerative Colitis Therapeutics Market
10.2.6.4.1 Spain Ulcerative Colitis Therapeutics Market by Drug Type
10.2.6.4.2 Spain Ulcerative Colitis Therapeutics Market by Disease Type
10.2.6.4.3 Spain Ulcerative Colitis Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom Ulcerative Colitis Therapeutics Market
10.2.6.5.1 United Kingdom Ulcerative Colitis Therapeutics Market by Drug Type
10.2.6.5.2 United Kingdom Ulcerative Colitis Therapeutics Market by Disease Type
10.2.6.5.3 United Kingdom Ulcerative Colitis Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Ulcerative Colitis Therapeutics Market Overview
10.3.2 Asia-Pacific Ulcerative Colitis Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Disease Type
10.3.5 Asia-Pacific Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Ulcerative Colitis Therapeutics Market
10.3.6.1.1 Australia Ulcerative Colitis Therapeutics Market by Drug Type
10.3.6.1.2 Australia Ulcerative Colitis Therapeutics Market by Disease Type
10.3.6.1.3 Australia Ulcerative Colitis Therapeutics Market by Distribution Channel
10.3.6.2 China Ulcerative Colitis Therapeutics Market
10.3.6.2.1 China Ulcerative Colitis Therapeutics Market by Drug Type
10.3.6.2.2 China Ulcerative Colitis Therapeutics Market by Disease Type
10.3.6.2.3 China Ulcerative Colitis Therapeutics Market by Distribution Channel
10.3.6.3 India Ulcerative Colitis Therapeutics Market
10.3.6.3.1 India Ulcerative Colitis Therapeutics Market by Drug Type
10.3.6.3.2 India Ulcerative Colitis Therapeutics Market by Disease Type
10.3.6.3.3 India Ulcerative Colitis Therapeutics Market by Distribution Channel
10.3.6.4 Japan Ulcerative Colitis Therapeutics Market
10.3.6.4.1 Japan Ulcerative Colitis Therapeutics Market by Drug Type
10.3.6.4.2 Japan Ulcerative Colitis Therapeutics Market by Disease Type
10.3.6.4.3 Japan Ulcerative Colitis Therapeutics Market by Distribution Channel
10.3.6.5 South Korea Ulcerative Colitis Therapeutics Market
10.3.6.5.1 South Korea Ulcerative Colitis Therapeutics Market by Drug Type
10.3.6.5.2 South Korea Ulcerative Colitis Therapeutics Market by Disease Type
10.3.6.5.3 South Korea Ulcerative Colitis Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Ulcerative Colitis Therapeutics Market Overview
10.4.2 Middle East and Africa Ulcerative Colitis Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Disease Type
10.4.5 Middle East and Africa Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Ulcerative Colitis Therapeutics Market
10.4.6.1.1 South Africa Ulcerative Colitis Therapeutics Market by Drug Type
10.4.6.1.2 South Africa Ulcerative Colitis Therapeutics Market by Disease Type
10.4.6.1.3 South Africa Ulcerative Colitis Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia Ulcerative Colitis Therapeutics Market
10.4.6.2.1 Saudi Arabia Ulcerative Colitis Therapeutics Market by Drug Type
10.4.6.2.2 Saudi Arabia Ulcerative Colitis Therapeutics Market by Disease Type
10.4.6.2.3 Saudi Arabia Ulcerative Colitis Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E Ulcerative Colitis Therapeutics Market
10.4.6.3.1 U.A.E Ulcerative Colitis Therapeutics Market by Drug Type
10.4.6.3.2 U.A.E Ulcerative Colitis Therapeutics Market by Disease Type
10.4.6.3.3 U.A.E Ulcerative Colitis Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Ulcerative Colitis Therapeutics Market Overview
10.5.2 South and Central America Ulcerative Colitis Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Disease Type
10.5.5 South and Central America Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Ulcerative Colitis Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Ulcerative Colitis Therapeutics Market
10.5.6.1.1 Brazil Ulcerative Colitis Therapeutics Market by Drug Type
10.5.6.1.2 Brazil Ulcerative Colitis Therapeutics Market by Disease Type
10.5.6.1.3 Brazil Ulcerative Colitis Therapeutics Market by Distribution Channel
10.5.6.2 Argentina Ulcerative Colitis Therapeutics Market
10.5.6.2.1 Argentina Ulcerative Colitis Therapeutics Market by Drug Type
10.5.6.2.2 Argentina Ulcerative Colitis Therapeutics Market by Disease Type
10.5.6.2.3 Argentina Ulcerative Colitis Therapeutics Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ULCERATIVE COLITIS THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBVIE INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. COSMO PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. EA PHARMA CO., LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. F. HOFFMANN-LA ROCHE LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON AND JOHNSON SERVICES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SALIX PHARMACEUTICALS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TAKEDA PHARMACEUTICAL COMPANY LIMITED.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. AbbVie Inc.
3. COSMO PHARMACEUTICALS
4. EA Pharma Co., Ltd.
5. F. Hoffmann-La Roche Ltd
6. Johnson and Johnson Services, Inc.
7. Pfizer Inc.
8. Salix Pharmaceuticals
9. Takeda Pharmaceutical Company Limited.
10. Teva Pharmaceutical Industries Ltd.
TIPRE00007751
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking